Octagon Biotech Opportunities Offshore Fund II LP research brief

CIK 2132968 Copy CIK

Generated Nov. 6, 2026, 3:50 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: NEW YORK NY. Reported legal jurisdiction: CAYMAN ISLANDS. These do not establish investor residence or where funds were deployed.

• July 2, 2026 · D · 0002132968-26-000001 · Source evidence

  Reported offering amount: 175000000 USD. Reported amount sold: 53900000 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Octagon Biotech Opportunities Offshore Fund II LP research brief,” CIK 2132968, retrieved Nov. 6, 2026, 3:50 p.m.. Cite the specific accessions used. No amounts have been summed.